X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3424) 3424
Book Review (595) 595
Publication (174) 174
Newsletter (117) 117
Magazine Article (22) 22
Newspaper Article (13) 13
Book Chapter (8) 8
Conference Proceeding (5) 5
Trade Publication Article (4) 4
Book / eBook (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2819) 2819
index medicus (2702) 2702
paroxetine (2285) 2285
female (1812) 1812
male (1605) 1605
psychiatry (1502) 1502
adult (1340) 1340
middle aged (1093) 1093
paroxetine - adverse effects (1091) 1091
pharmacology & pharmacy (1035) 1035
serotonin uptake inhibitors - adverse effects (1017) 1017
paroxetine - therapeutic use (915) 915
antidepressants (894) 894
serotonin uptake inhibitors - therapeutic use (867) 867
fluoxetine (798) 798
aged (687) 687
treatment outcome (675) 675
depression (667) 667
double-blind (607) 607
depressive disorder - drug therapy (589) 589
sertraline (511) 511
neurosciences (510) 510
double-blind method (497) 497
clinical neurology (475) 475
antidepressive agents - therapeutic use (450) 450
antidepressive agents, second-generation - adverse effects (444) 444
antidepressive agents - adverse effects (421) 421
serotonin reuptake inhibitors (421) 421
depressive disorder, major - drug therapy (419) 419
adolescent (400) 400
antidepressive agents, second-generation - therapeutic use (388) 388
drug therapy (387) 387
serotonin (380) 380
efficacy (348) 348
major depression (338) 338
psychiatric status rating scales (333) 333
dose-response relationship, drug (326) 326
paroxetine - administration & dosage (307) 307
abridged index medicus (302) 302
depression - drug therapy (292) 292
major depressive disorder (292) 292
depression, mental (291) 291
placebo (290) 290
serotonin uptake inhibitors - administration & dosage (276) 276
serotonin uptake inhibitors (273) 273
risk factors (264) 264
citalopram (252) 252
research (248) 248
drug interactions (245) 245
fluvoxamine (242) 242
medicine, general & internal (241) 241
psychology, clinical (236) 236
animals (231) 231
care and treatment (229) 229
venlafaxine (229) 229
drug therapy, combination (225) 225
paroxetine - pharmacology (223) 223
pregnancy (221) 221
mental depression (217) 217
depressive disorder - psychology (215) 215
drug administration schedule (215) 215
drugs (211) 211
serotonin uptake inhibitors - pharmacology (211) 211
analysis (209) 209
time factors (204) 204
anxiety (200) 200
fluoxetine - adverse effects (198) 198
clinical trials (197) 197
medicine & public health (196) 196
antidepressant (193) 193
fluoxetine - therapeutic use (192) 192
risk (189) 189
health aspects (177) 177
venlafaxine hydrochloride (176) 176
randomized controlled trials as topic (171) 171
ssri (167) 167
aged, 80 and over (164) 164
young adult (164) 164
placebo-controlled trial (163) 163
dosage and administration (162) 162
citalopram - therapeutic use (157) 157
symptoms (154) 154
child (152) 152
complications and side effects (150) 150
pharmacotherapy (148) 148
disorder (146) 146
selective serotonin reuptake inhibitors (145) 145
antidepressive agents, tricyclic - therapeutic use (141) 141
imipramine (141) 141
pharmacology (141) 141
sertraline - therapeutic use (139) 139
citalopram - adverse effects (137) 137
psychology (137) 137
severity of illness index (137) 137
pharmacology/toxicology (136) 136
antidepressive agents, second-generation - administration & dosage (134) 134
anxiety disorders - drug therapy (134) 134
safety (134) 134
pharmacokinetics (133) 133
prevalence (131) 131
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3416) 3416
French (37) 37
Spanish (32) 32
German (29) 29
Dutch (16) 16
Norwegian (13) 13
Japanese (9) 9
Swedish (7) 7
Russian (6) 6
Danish (4) 4
Italian (4) 4
Chinese (2) 2
Polish (2) 2
Portuguese (2) 2
Czech (1) 1
Hebrew (1) 1
Hungarian (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological Psychiatry, ISSN 0006-3223, 2003, Volume 54, Issue 9, pp. 879 - 883
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2011, Volume 185, Issue 2, pp. 638 - 639
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 04/2008, Volume 28, Issue 2, pp. 156 - 165
Journal Article
Journal Article
Research in Developmental Disabilities, ISSN 0891-4222, 11/2012, Volume 33, Issue 6, pp. 2106 - 2121
Journal Article
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, ISSN 0815-9319, 07/2012, Volume 27, Issue 7, pp. 1233 - 1240
Background and Aims: Pegylated interferon (PEG-IFN) a-2b and ribavirin (RBV) treatment of chronic hepatitis C virus (HCV) infection is associated with a... 
DEPRESSION | PLUS RIBAVIRIN | ribavirin | TELAPREVIR | ALPHA | pegylated interferon | SYMPTOMS | VIROLOGICAL RESPONSE | PEGINTERFERON | TRIAL | THERAPY | adverse effect | hepatitis C virus | PAROXETINE | GASTROENTEROLOGY & HEPATOLOGY | Side effects | Liver diseases | Sex | Chronic infection | Interferon | Age | Ribavirin
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 04/2009, Volume 166, Issue 4, pp. 418 - 426
Objective: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of... 
TRIALS | METAANALYSIS | INVENTORY | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | RISK | TADS | SCALE | IDEATION | CHILDREN | Cyclohexanols - adverse effects | Humans | Suicide, Attempted - statistics & numerical data | Citalopram - adverse effects | Male | Paroxetine - therapeutic use | Paroxetine - adverse effects | Drug Interactions | Self-Injurious Behavior - epidemiology | Suicide - psychology | Female | Fluoxetine - therapeutic use | Drug Therapy, Combination | Drug Resistance | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Cross-Sectional Studies | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Suicide - statistics & numerical data | Antidepressive Agents - therapeutic use | Suicide, Attempted - psychology | Venlafaxine Hydrochloride | Self-Injurious Behavior - chemically induced | Adolescent | Cyclohexanols - therapeutic use | Citalopram - therapeutic use | Cognitive Therapy | Benzodiazepines - adverse effects | Antidepressive Agents - adverse effects | Benzodiazepines - therapeutic use | Cognitive therapy | Venlafaxine | Influence | Serotonin uptake inhibitors | Dosage and administration | Suicide | Drug therapy | Self-destructive behavior | Risk factors | Depression in adolescence | Methods | Studies | Cognition & reasoning | Suicides & suicide attempts | Clinical trials | Teenagers | Behavior | Mental depression | Alcohol use | Depressive Disorders | Drug Abuse | SSRIs | Comorbidity | Survivors | Americans | Cognitive Behavioral Therapy | Self Inflicted Wounds | Self Destructive Behavior | Benzodiazepines | Randomized Clinical Trial | Atypical Antidepressants | Suicidality | Predisposition | Interpersonal Interaction | Alcohol Abuse | Adolescents | Negative Therapeutic Reaction | Stressors | Index Medicus | Abridged Index Medicus
Journal Article
12/2010
Cross-sensitivity due to paroxetine and sertraline, the SSRIs, is rarely reported in the literature. We report an adverse drug reaction to paroxetine and... 
paroxetine | cross-sensitivity | sertralineIntroduction | Cutaneous adverse effects
Web Resource
CMAJ, ISSN 0820-3946, 11/2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged